Cargando…
Dichloroacetate and Pyruvate Metabolism: Pyruvate Dehydrogenase Kinases as Targets Worth Investigating for Effective Therapy of Toxoplasmosis
Toxoplasmosis, a protozoan infection caused by Toxoplasma gondii, is estimated to affect around 2.5 billion people worldwide. Nevertheless, the side effects of drugs combined with the long period of therapy usually result in discontinuation of the treatment. New therapies should be developed by expl...
Autores principales: | Ferrarini, Mariana Galvão, Nisimura, Lindice Mitie, Girard, Richard Marcel Bruno Moreira, Alencar, Mayke Bezerra, Fragoso, Mariana Sayuri Ishikawa, Araújo-Silva, Carlla Assis, Veiga, Alan de Almeida, Abud, Ana Paula Ressetti, Nardelli, Sheila Cristina, Vommaro, Rossiane C., Silber, Ariel Mariano, France-Sagot, Marie, Ávila, Andréa Rodrigues |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845590/ https://www.ncbi.nlm.nih.gov/pubmed/33408226 http://dx.doi.org/10.1128/mSphere.01002-20 |
Ejemplares similares
-
Dichloroacetate, the Pyruvate Dehydrogenase Complex and the Modulation of mESC Pluripotency
por: Rodrigues, Ana Sofia, et al.
Publicado: (2015) -
Comparison Between Dichloroacetate and Phenylbutyrate Treatment for Pyruvate Dehydrogenase Deficiency
por: Karissa, Patricia, et al.
Publicado: (2022) -
Regulation of Muscle Pyruvate Dehydrogenase Complex in Insulin Resistance: Effects of Exercise and Dichloroacetate
por: Constantin-Teodosiu, Dumitru
Publicado: (2013) -
Pyruvate Dehydrogenase Kinase Inhibition by Dichloroacetate in Melanoma Cells Unveils Metabolic Vulnerabilities
por: Tiersma, Jiske F., et al.
Publicado: (2022) -
Combined Treatment of Dichloroacetic Acid and Pyruvate Increased Neuronal Survival after Seizure
por: Lee, Song Hee, et al.
Publicado: (2022)